(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Canopy Growth, VerifyMe, and Novavax.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Canopy Growth (CGC) | 0.79 | 14.81% | 2023-09-06 14:40:13 |
| 2 | VerifyMe (VRME) | 1.30 | 14.04% | 2023-09-06 12:52:11 |
| 3 | Novavax (NVAX) | 9.83 | 8.64% | 2023-09-06 14:30:16 |
| 4 | DexCom (DXCM) | 107.50 | 7.15% | 2023-09-06 14:27:50 |
| 5 | Upland Software (UPLD) | 4.01 | 5.12% | 2023-09-06 14:16:37 |
| 6 | Spectra Energy (SE) | 39.15 | 4.93% | 2023-09-06 13:00:00 |
| 7 | Viking Therapeutics (VKTX) | 14.77 | 4.27% | 2023-09-06 14:34:19 |
| 8 | Insulet (PODD) | 193.62 | 3.56% | 2023-09-06 14:30:33 |
| 9 | Vail Resorts (MTN) | 235.93 | 3.52% | 2023-09-05 19:09:07 |
| 10 | Gyrodyne (GYRO) | 10.60 | 3.41% | 2023-09-06 13:13:22 |
The three biggest losers today are AMC, Pitney Bowes, and McEwen Mining.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | AMC (AMC) | 8.51 | -37.62% | 2023-09-06 14:34:55 |
| 2 | Pitney Bowes (PBI) | 3.00 | -8.81% | 2023-09-06 07:46:09 |
| 3 | McEwen Mining (MUX) | 7.23 | -8.02% | 2023-09-05 19:43:07 |
| 4 | Lyft (LYFT) | 10.96 | -7.43% | 2023-09-06 14:33:04 |
| 5 | Peloton (PTON) | 6.11 | -7.36% | 2023-09-06 14:33:34 |
| 6 | Snap (SNAP) | 9.69 | -7.36% | 2023-09-06 13:02:56 |
| 7 | FuboTV (FUBO) | 2.70 | -7.22% | 2023-09-06 13:02:32 |
| 8 | Minerals Technologies (MTX) | 57.45 | -6.45% | 2023-09-05 19:12:06 |
| 9 | Enpro Industries (NPO) | 129.13 | -6.15% | 2023-09-06 01:44:07 |
| 10 | FibroGen (FGEN) | 0.99 | -6.14% | 2023-09-06 14:28:17 |
Winners today
1. Canopy Growth (CGC) – 14.81%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth jumping 14.81% to $0.79 on Wednesday, after two successive sessions in a row of gains. NASDAQ slid 1.06% to $13,872.47, after two sequential sessions in a row of losses, on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-1.69.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.56%.
Volatility
Canopy Growth’s last week, last month’s, and last quarter’s current intraday variation average was 10.87%, 1.74%, and 7.97%.
Canopy Growth’s highest amplitude of average volatility was 14.87% (last week), 6.29% (last month), and 7.97% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 405.71M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Canopy Growth’s EBITDA is 1.84.
More news about Canopy Growth.
2. VerifyMe (VRME) – 14.04%
VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, traceability, consumer engagement solutions, and authentication for labels, packaging, and products, as well as tamper-proof labels. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Lake Mary, Florida.
NASDAQ ended the session with VerifyMe rising 14.04% to $1.30 on Wednesday, following the last session’s downward trend. NASDAQ dropped 1.06% to $13,872.47, after two successive sessions in a row of losses, on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, VerifyMe has a trailing twelve months EPS of $-0.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.44%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.6%, now sitting on 25.91M for the twelve trailing months.
Yearly Top and Bottom Value
VerifyMe’s stock is valued at $1.30 at 17:32 EST, way below its 52-week high of $2.27 and way above its 52-week low of $1.01.
Volume
Today’s last reported volume for VerifyMe is 47056 which is 260.63% above its average volume of 13048.
Volatility
VerifyMe’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.45%, a negative 0.18%, and a positive 2.14%.
VerifyMe’s highest amplitude of average volatility was 1.33% (last week), 2.59% (last month), and 2.14% (last quarter).
More news about VerifyMe.
3. Novavax (NVAX) – 8.64%
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
NASDAQ ended the session with Novavax jumping 8.64% to $9.83 on Wednesday while NASDAQ slid 1.06% to $13,872.47.
Earnings Per Share
As for profitability, Novavax has a trailing twelve months EPS of $-7.33.
Volatility
Novavax’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.94%, a positive 0.15%, and a positive 4.21%.
Novavax’s highest amplitude of average volatility was 3.57% (last week), 4.58% (last month), and 4.21% (last quarter).
Previous days news about Novavax
- Novavax (nvax) stock increases 9% in a month: here's why. According to Zacks on Tuesday, 5 September, "Alongside its second-quarter 2023 results, Novavax announced that it had initiated a filing with the FDA for this updated COVID-19 vaccine and intends to submit one in Europe in the coming weeks. ", "With Novavax currently struggling with cash flow needs, a surge for COVID-19 vaccines will help the company generate additional cash resources to fund its business operations. "
More news about Novavax.
4. DexCom (DXCM) – 7.15%
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
NASDAQ ended the session with DexCom rising 7.15% to $107.50 on Wednesday while NASDAQ fell 1.06% to $13,872.47.
Earnings Per Share
As for profitability, DexCom has a trailing twelve months EPS of $0.87.
PE Ratio
DexCom has a trailing twelve months price to earnings ratio of 123.56. Meaning, the purchaser of the share is investing $123.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.41%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
DexCom’s EBITDA is 12.28.
Volatility
DexCom’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.76%, a negative 0.86%, and a positive 1.79%.
DexCom’s highest amplitude of average volatility was 1.66% (last week), 2.28% (last month), and 1.79% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 21.4% and 11.8%, respectively.
More news about DexCom.
5. Upland Software (UPLD) – 5.12%
Upland Software, Inc. provides cloud-based enterprise work management software in the United States, the United Kingdom, Canada, and internationally. It offers a family of software applications under the Upland brand in the areas of marketing, sales, contact center, project management, information technology, business operations, and human resources and legal. The company also provides professional services, such as implementation, data extraction, integration and configuration, and training services, as well as customer support services. It serves large global corporations, various government agencies, and small and medium-sized businesses, as well as financial, consulting, technology, manufacturing, media, telecommunication, political, healthcare, life sciences, and retail and hospitality sectors. The company was formerly known as Silverback Enterprise Group, Inc. and changed its name to Upland Software, Inc. in November 2013. Upland Software, Inc. was incorporated in 2010 and is headquartered in Austin, Texas.
NASDAQ ended the session with Upland Software rising 5.12% to $4.01 on Wednesday while NASDAQ fell 1.06% to $13,872.47.
Earnings Per Share
As for profitability, Upland Software has a trailing twelve months EPS of $-7.39.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -62.01%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 58% and a negative 45.9%, respectively.
Yearly Top and Bottom Value
Upland Software’s stock is valued at $4.01 at 17:32 EST, way below its 52-week high of $11.88 and way above its 52-week low of $2.47.
Revenue Growth
Year-on-year quarterly revenue growth declined by 7.1%, now sitting on 309.91M for the twelve trailing months.
More news about Upland Software.
6. Spectra Energy (SE) – 4.93%
Sea Limited, together with its subsidiaries, engages in the digital entertainment, e-commerce, and digital financial service businesses in Southeast Asia, Latin America, rest of Asia, and internationally. It offers Garena digital entertainment platform for users to access mobile and PC online games, as well as eSports operations. The company also operates Shopee e-commerce platform, a mobile-centric marketplace that provides integrated payment and logistics infrastructure and seller services. In addition, it offers SeaMoney digital financial services to individuals and businesses, including offline and online mobile wallet, and payment processing services, as well as other offerings across credit, insurtech, and digital bank services under the ShopeePay, SPayLater, SeaBank, SeaInsure, and other digital financial services brands; and payment processing services for Shopee. The company was formerly known as Garena Interactive Holding Limited and changed its name to Sea Limited in April 2017. Sea Limited was incorporated in 2009 and is headquartered in Singapore.
NYSE ended the session with Spectra Energy rising 4.93% to $39.15 on Wednesday while NYSE slid 0.32% to $15,891.53.
Earnings Per Share
As for profitability, Spectra Energy has a trailing twelve months EPS of $0.45.
PE Ratio
Spectra Energy has a trailing twelve months price to earnings ratio of 87. Meaning, the purchaser of the share is investing $87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.51%.
Volatility
Spectra Energy’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.79%, a negative 4.20%, and a positive 2.99%.
Spectra Energy’s highest amplitude of average volatility was 1.59% (last week), 5.39% (last month), and 2.99% (last quarter).
More news about Spectra Energy.
7. Viking Therapeutics (VKTX) – 4.27%
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
NASDAQ ended the session with Viking Therapeutics rising 4.27% to $14.77 on Wednesday, following the last session’s downward trend. NASDAQ fell 1.06% to $13,872.47, after two sequential sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.96.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.88%.
More news about Viking Therapeutics.
8. Insulet (PODD) – 3.56%
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
NASDAQ ended the session with Insulet rising 3.56% to $193.62 on Wednesday while NASDAQ fell 1.06% to $13,872.47.
Earnings Per Share
As for profitability, Insulet has a trailing twelve months EPS of $0.9.
PE Ratio
Insulet has a trailing twelve months price to earnings ratio of 215.13. Meaning, the purchaser of the share is investing $215.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.88%.
Volume
Today’s last reported volume for Insulet is 1043840 which is 22.76% above its average volume of 850295.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Insulet’s EBITDA is 9.24.
More news about Insulet.
9. Vail Resorts (MTN) – 3.52%
Vail Resorts, Inc., through its subsidiaries, operates mountain resorts and regional ski areas in the United States. It operates through three segments: Mountain, Lodging, and Real Estate. The Mountain segment operates 41 destination mountain resorts and regional ski areas. This segment is also involved in the ancillary activities, including ski school, dining, and retail/rental operations, as well as real estate brokerage activities. The Lodging segment owns and/or manages various luxury hotels and condominiums, and other lodging properties under the RockResorts brand; various condominiums located in proximity to the company's mountain resorts; destination resorts; and golf courses, as well as offers resort ground transportation services. This segment operates owned and managed hotel and condominium units. The Real Estate segment owns, develops, and sells real estate properties. The company was founded in 1845 and is based in Broomfield, Colorado.
NYSE ended the session with Vail Resorts jumping 3.52% to $235.93 on Wednesday, after two consecutive sessions in a row of gains. NYSE dropped 0.32% to $15,891.53, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Vail Resorts has a trailing twelve months EPS of $7.22.
PE Ratio
Vail Resorts has a trailing twelve months price to earnings ratio of 32.68. Meaning, the purchaser of the share is investing $32.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.92%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Vail Resorts’s EBITDA is 19.95.
Sales Growth
Vail Resorts’s sales growth for the current quarter is 6.2%.
More news about Vail Resorts.
10. Gyrodyne (GYRO) – 3.41%
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.
NASDAQ ended the session with Gyrodyne rising 3.41% to $10.60 on Wednesday while NASDAQ slid 1.06% to $13,872.47.
Earnings Per Share
As for profitability, Gyrodyne has a trailing twelve months EPS of $0.19.
PE Ratio
Gyrodyne has a trailing twelve months price to earnings ratio of 55.79. Meaning, the purchaser of the share is investing $55.79 for every dollar of annual earnings.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 2.74M for the twelve trailing months.
Yearly Top and Bottom Value
Gyrodyne’s stock is valued at $10.60 at 17:32 EST, way below its 52-week high of $12.66 and way above its 52-week low of $7.80.
More news about Gyrodyne.
Losers Today
1. AMC (AMC) – -37.62%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC sliding 37.62% to $8.51 on Wednesday, after two successive sessions in a row of gains. NYSE fell 0.32% to $15,891.53, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
: AMC stock tumbles after filing prospectus supplement for the sale of up to 40 million sharesShares of AMC Entertainment Holdings Inc. tumbled Thursday after the movie-theater operator disclosed an equity-distribution agreement in which the company could sell up to 40 million common shares.
AMC shares tumble toward lowest levels since January 2021Shares of AMC Entertainment Holdings Inc. tumbled Thursday after the movie-theater operator disclosed an equity-distribution agreement in which the company could sell up to 40 million common shares.
AMC shares stumble after filing of stock-issuance prospectusShares of AMC Entertainment Holdings Inc. tumbled Thursday after the movie-theater operator disclosed an equity-distribution agreement in which the company could sell up to 40 million common shares.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-5.99.
More news about AMC.
2. Pitney Bowes (PBI) – -8.81%
Pitney Bowes Inc., a shipping and mailing company, provides technology, logistics, and financial services to small and medium-sized businesses, large enterprises, retailers, and government clients in the United States, Canada, and internationally. It operates through Global Ecommerce, Presort Services, and Sending Technology Solutions (SendTech Solutions) segments. The Global Ecommerce segment provides domestic parcel services, cross-border solutions, and digital delivery services. The Presort Services segment offers mail sortation services, which allow clients to qualify volumes of first-class mail, marketing mail, and bound and packet mail for postal work sharing discounts. The SendTech Solutions segment provides physical and digital mailing and shipping technology solutions and other applications for sending, tracking and receiving of letters, parcels, and flats as well as financing alternatives to finance equipment and product purchases. Pitney Bowes Inc. markets its products, solutions, and services through direct and inside sales force, global and regional partner channels, direct mailings, and digital channels. The company was formerly known as Pitney Bowes Postage Meter Company. Pitney Bowes Inc. was incorporated in 1920 and is headquartered in Stamford, Connecticut.
NYSE ended the session with Pitney Bowes falling 8.81% to $3.00 on Wednesday while NYSE dropped 0.32% to $15,891.53.
Earnings Per Share
As for profitability, Pitney Bowes has a trailing twelve months EPS of $-0.78.
Sales Growth
Pitney Bowes’s sales growth is negative 4.9% for the current quarter and 3.7% for the next.
More news about Pitney Bowes.
3. McEwen Mining (MUX) – -8.02%
McEwen Mining Inc. engages in the exploration, development, production, and sale of gold and silver deposits in the United States, Canada, Mexico, and Argentina. The company also explores for copper deposits. It primarily owns a 100% interest in the Gold Bar mine in Eureka County, Nevada; the Fox Complex in Ontario, Canada; the El Gallo Project and Fenix silver-gold project in Sinaloa, Mexico; the Los Azules copper deposit in San Juan, Argentina; and a portfolio of exploration properties in Nevada, Canada, Mexico, and Argentina. It also owns a 49% interest in the San José mine located in Argentina. The company was formerly known as US Gold Corporation and changed its name to McEwen Mining Inc. in January 2012. McEwen Mining Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.
NYSE ended the session with McEwen Mining sliding 8.02% to $7.23 on Wednesday, after four sequential sessions in a row of losses. NYSE slid 0.32% to $15,891.53, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, McEwen Mining has a trailing twelve months EPS of $-2.31.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.35%.
Sales Growth
McEwen Mining’s sales growth is 74.8% for the present quarter and 47.4% for the next.
Moving Average
McEwen Mining’s value is below its 50-day moving average of $7.74 and under its 200-day moving average of $7.24.
More news about McEwen Mining.
4. Lyft (LYFT) – -7.43%
Lyft, Inc. operates a peer-to-peer marketplace for on-demand ridesharing in the United States and Canada. The company operates multimodal transportation networks that offer riders personalized and on-demand access to various mobility options. It provides Ridesharing Marketplace, which connects drivers with riders; Express Drive, a flexible car rentals program for drivers; Lyft Rentals that provides vehicles for long-distance trips; and a network of shared bikes and scooters in various cities to address the needs of riders for short trips. The company also integrates third-party public transit data into the Lyft app to offer riders various transportation options. In addition, it offers access to autonomous vehicles; centralized tools and enterprise transportation solutions, such as concierge transportation solutions for organizations; Lyft Pink subscription plans; Lyft Pass commuter programs; first-mile and last-mile services; and university safe rides programs. The company was formerly known as Zimride, Inc. and changed its name to Lyft, Inc. in April 2013. Lyft, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.
NASDAQ ended the session with Lyft dropping 7.43% to $10.96 on Wednesday, following the last session’s downward trend. NASDAQ dropped 1.06% to $13,872.47, after two successive sessions in a row of losses, on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, Lyft has a trailing twelve months EPS of $-3.79.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -193.79%.
Moving Average
Lyft’s value is below its 50-day moving average of $11.01 and below its 200-day moving average of $10.97.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Lyft’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Lyft is 11803000 which is 24.08% below its average volume of 15547800.
More news about Lyft.
5. Peloton (PTON) – -7.36%
Peloton Interactive, Inc. operates interactive fitness platform in North America and internationally. The company offers connected fitness products with touchscreen that streams live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread, Peloton Tread+, Peloton Guide, and Peloton Row names. The company markets and sells its interactive fitness products directly through its retail showrooms and at onepeloton.com. Peloton Interactive, Inc. was founded in 2012 and is headquartered in New York, New York.
NASDAQ ended the session with Peloton falling 7.36% to $6.11 on Wednesday, after five sequential sessions in a row of gains. NASDAQ fell 1.06% to $13,872.47, after two sequential sessions in a row of losses, on what was an all-around down trend exchanging session today.
Earnings Per Share
As for profitability, Peloton has a trailing twelve months EPS of $-3.82.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -847.35%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Peloton’s EBITDA is 1.3.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.4%, now sitting on 2.8B for the twelve trailing months.
More news about Peloton.
6. Snap (SNAP) – -7.36%
Snap Inc. operates as a technology company in North America, Europe, and internationally. The company offers Snapchat, a visual messaging application with various tabs, such as camera, visual messaging, snap map, stories, and spotlight that enable people to communicate visually through short videos and images. It also provides Spectacles, an eyewear product that connects with Snapchat and captures photos and video from a human perspective; and advertising products, including AR ads and Snap ads comprises a single image or video ads, story ads, collection ads, dynamic ads, and commercials. The company was formerly known as Snapchat, Inc. and changed its name to Snap Inc. in September 2016. Snap Inc. was founded in 2010 and is headquartered in Santa Monica, California.
NYSE ended the session with Snap dropping 7.36% to $9.69 on Wednesday, after five successive sessions in a row of gains. NYSE slid 0.32% to $15,891.53, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Snap has a trailing twelve months EPS of $-0.86.
More news about Snap.
7. FuboTV (FUBO) – -7.22%
fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.
NYSE ended the session with FuboTV dropping 7.22% to $2.70 on Wednesday while NYSE slid 0.32% to $15,891.53.
Earnings Per Share
As for profitability, FuboTV has a trailing twelve months EPS of $-1.77.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 61% and 57.9%, respectively.
Volume
Today’s last reported volume for FuboTV is 12955000 which is 21.58% below its average volume of 16521800.
More news about FuboTV.
8. Minerals Technologies (MTX) – -6.45%
Minerals Technologies Inc. develops, produces, and markets various specialty mineral, mineral-based, and synthetic mineral products, and supporting systems and services. The company operates through three segments: Performance Materials, Specialty Minerals and Refractories. The Performance Materials segment supplies bentonite and bentonite-related products, as well as leonardite. This segment also offers metal casting products; household, personal care, and specialty products; and basic minerals, environmental products, and building materials. The Specialty Minerals segment produces and sells precipitated calcium carbonate and quicklime; and provides natural mineral products comprising limestone and talc. This segment's products are used in paper and packaging, building materials, paint and coatings, glass, ceramic, polymer, food, automotive, and pharmaceutical industries. The Refractories segment offers monolithic and shaped refractory materials; specialty products, services, and application and measurement equipment; and calcium metal and metallurgical wire products that are used in the applications of steel, non-ferrous metal, and glass industries. It markets its products primarily through its direct sales force, as well as regional distributors. The company serves in the United States, Canada, Latin America, Europe, Africa, and Asia. The company was incorporated in 1968 and is headquartered in New York, New York.
NYSE ended the session with Minerals Technologies falling 6.45% to $57.45 on Wednesday while NYSE fell 0.32% to $15,891.53.
Earnings Per Share
As for profitability, Minerals Technologies has a trailing twelve months EPS of $3.
PE Ratio
Minerals Technologies has a trailing twelve months price to earnings ratio of 19.15. Meaning, the purchaser of the share is investing $19.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.28%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1%, now sitting on 2.15B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 16, 2023, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 0.33%.
Moving Average
Minerals Technologies’s value is under its 50-day moving average of $57.62 and below its 200-day moving average of $59.54.
More news about Minerals Technologies.
9. Enpro Industries (NPO) – -6.15%
EnPro Industries, Inc. design, develops, manufactures, and markets proprietary, value-added products and solutions to safeguard critical environments in the United States and internationally. It operates through two segments, Sealing Technologies and Advanced Surface Technologies. The Sealing Technologies segment offers single-use hygienic seals, tubing, components and assemblies; metallic, non-metallic, and composite material gaskets; compression packing products; hydraulic components; expansion joints; wall penetration products; and dynamic seals, resilient metal, elastomeric, and custom-engineered mechanical seals for chemical and petrochemical processing, pulp and paper processing, power generation, food and pharmaceutical processing, primary metal manufacturing, mining, water and waste treatment, heavy-duty trucking, aerospace, medical, filtration, and semiconductor fabrication industries. The Advanced Surface Technologies segment offers cleaning, coating, testing, refurbishment, and verification services for critical components and assemblies used in semiconductor manufacturing equipment, as well as for critical applications in the space, aerospace, and defense markets; and specialized optical filters and thin-film coatings for various applications in the industrial technology, life sciences, and semiconductor markets. EnPro Industries, Inc. was incorporated in 2002 and is headquartered in Charlotte, North Carolina.
NYSE ended the session with Enpro Industries falling 6.15% to $129.13 on Wednesday while NYSE dropped 0.32% to $15,891.53.
Earnings Per Share
As for profitability, Enpro Industries has a trailing twelve months EPS of $-1.16.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.26%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 28, 2023, the estimated forward annual dividend rate is 1.16 and the estimated forward annual dividend yield is 0.84%.
Moving Average
Enpro Industries’s worth is below its 50-day moving average of $134.33 and way above its 200-day moving average of $114.80.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.1%, now sitting on 1.11B for the twelve trailing months.
More news about Enpro Industries.
10. FibroGen (FGEN) – -6.14%
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
NASDAQ ended the session with FibroGen falling 6.14% to $0.99 on Wednesday, following the last session’s downward trend. NASDAQ slid 1.06% to $13,872.47, after two successive sessions in a row of losses, on what was an all-around bearish trend exchanging session today.
Earnings Per Share
As for profitability, FibroGen has a trailing twelve months EPS of $-3.7.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1015.79%.
Yearly Top and Bottom Value
FibroGen’s stock is valued at $0.99 at 17:32 EST, way below its 52-week high of $25.69 and higher than its 52-week low of $0.91.
Volume
Today’s last reported volume for FibroGen is 3383540 which is 12.63% below its average volume of 3872980.
Sales Growth
FibroGen’s sales growth is 134.7% for the present quarter and 14.6% for the next.
More news about FibroGen.
Stay up to date with our winners and losers daily report
